HIGH GRADE OSTEOSARCOMA
Clinical trials for HIGH GRADE OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH GRADE OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for HIGH GRADE OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a targeted drug boost chemo for osteosarcoma?
Disease control TerminatedThis trial is testing whether adding the targeted drug cabozantinib to standard chemotherapy (methotrexate, doxorubicin, and cisplatin) helps people with newly diagnosed osteosarcoma, a type of bone cancer. The study includes over 1,100 participants and aims to see if the combina…
Matched conditions: HIGH GRADE OSTEOSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Blood test could revolutionize sarcoma monitoring
Knowledge-focused OngoingThis study is testing whether a liquid biopsy (a blood test that detects tumor DNA) can help predict outcomes for people with Ewing sarcoma or osteosarcoma. Researchers will collect blood samples from 340 patients at diagnosis and track their health over time. The goal is to see …
Matched conditions: HIGH GRADE OSTEOSARCOMA
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC